IA
TRML

IFP Advisors’s Tourmaline Bio TRML Stock Holding History

IFP Advisors’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Hold
0
– – – 4352
2023
Q1 		– Sell
-547
Closed -$89K – 4360
2022
Q4 		$89K Hold
547
– – ﹤0.01% 1820
2022
Q3 		$89K Buy
547
+500
+1,064% +$18.2K ﹤0.01% 1943
2022
Q2 		$8K Hold
47
– – ﹤0.01% 3559
2022
Q1 		$8K Buy
+47
New +$4.4K ﹤0.01% 3558

Other funds holding TRML

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

IFP Advisors's TRML Position: Q2 2025 in Review

IFP Advisors held its Tourmaline Bio (TRML) position steady in Q2 2025 at 0 shares worth $656. The position accounts for ﹤0.01% of the portfolio, ranked #4352.

IFP Advisors first reported a position in TRML in Q1 2022 and has held it in 4 quarters since. The position peaked at $89K in Q4 2022. 108 funds tracked by Wall St. Rank hold TRML as of Q2 2025.

  • IFP Advisors held 0 shares of Tourmaline Bio worth $656 as of Q2 2025.
  • IFP Advisors left its Tourmaline Bio share count unchanged in Q2 2025.
  • Tourmaline Bio made up ﹤0.01% of IFP Advisors's portfolio in Q2 2025, its #4352 holding.
  • IFP Advisors first reported a position in Tourmaline Bio in Q1 2022 and has held it in 4 quarters since.
  • IFP Advisors's Tourmaline Bio position peaked at $89K in Q4 2022.
  • 108 funds tracked by Wall St. Rank held Tourmaline Bio as of Q2 2025.

Based on IFP Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.